Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adderall-XR for Comorbid ADHD and Cocaine Dependence
NCT00553319Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Dec 2007
- Primary completion
- Jul 2013
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of adderall xr in cocaine dependence, attention deficit hyperactivity disorder (ADHD), sponsored by New York State Psychiatric Institute. Started Dec 2007; status: completed.
02
Drugs
adderall xr
03
Conditions
cocaine dependenceattention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00553319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553319.